# US 2026/0265055 A1 · Sulfine-Based Compounds for Generating Hydrogen Persulfide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0265055 A1
- Document ID: US20260265055A1
- Status: Published application
- Kind: A1
- Application number: 19/165,221
- Filed: 2024-03-15
- Published: 2026-09-10
- Earliest claimed: 2023-03-16
- Assignees: Brown University
- Applicants: Brown University
- Inventors: Ming Xian; Qi Cui; Meg Shieh
- Web page: https://patentgrep.com/patent/US20260265055A1

## CPC

- C01B 17/18: Hydrogen polysulfides
- C07D 335/02: not condensed with other rings
- C07D 335/06: Benzothiopyrans; Hydrogenated benzothiopyrans
- C07D 339/04: having the hetero atoms in positions 1 and 2, e.g. lipoic acid
- C07F 9/655363: {the sulfur atom being part of a six-membered ring}
- C01P 2002/84: by UV- or VIS- data
- C01P 2002/86: by NMR- or ESR-data
- C01P 2002/89: by mass-spectroscopy
- C07B 59/002: {Heterocyclic compounds}
- C01B: NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; {METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C01P: INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Embodiments described herein are directed to compounds and methods for generating hydrogen persulfide. In particular, the disclosure provides compounds including a stable sulfine moiety which reacts with hydrogen sulfide, such as at a site within an individual, and ultimately generates hydrogen persulfide, such as in vivo within the individual.

## Claims

### Claim 1

A method of generating H2S2 comprising
reacting a compound comprising a sulfine moiety with H2S directly or generated by an H2S donor to generate H2S2.

### Claim 2 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety further comprises an aromatic heterocycle.

### Claim 3 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety further comprises an aromatic heterocycle substituted at one or more locations on the heterocycle.

### Claim 4 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety further comprises an aromatic heterocycle substituted at one or more locations on the heterocycle with a carboxyl group or an ester.

### Claim 5 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety further comprises an aromatic six-membered heterocycle wherein the carbon atom of the sulfine moiety is within the heterocycle and the heterocycle substituted at the C4 location with a carboxyl group or an ester.

### Claim 6 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is compound
X1 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R1 is absent when X1 is oxygen, sulfur or double bonded nitrogen;
X2 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R2 is absent when X2 is oxygen, sulfur or double bonded nitrogen;
X3 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R3 is absent when X3 is oxygen, sulfur or double bonded nitrogen;
X4 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon, atom wherein R4 is absent when X4 is oxygen, sulfur or double bonded nitrogen;
X5 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R5 is absent when X5 is oxygen, sulfur or double bonded nitrogen;
with the proviso that no more than two of X1, X2, X3, X4, X5 may be an atom other than carbon, i.e. a heteroatom,
R1 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R2 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R3 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R4 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker; and
R5 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker.
R1, R2, R3, R4, and R5 may be the same or different,
wherein R1, R2, R3, R4, or R5 or the linker may optionally be bound to a protein, antibody, receptor, ligand, antibody, delivery molecule, device, particle or H2S donating compound.

### Claim 7 (depends on 6)

The method of claim 6 wherein the compound is

### Claim 8 (depends on 6)

The method of claim 6 wherein the compound is
where X1 is sulfur, oxygen or nitrogen.

### Claim 9 (depends on 6)

The method of claim 6 wherein the compound is

### Claim 10 (depends on 6)

The method of claim 6 wherein the compound is

### Claim 11 (depends on 6)

The method of claim 6 wherein the compound is

### Claim 12 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is attached to a delivery agent for a location-specific site within a tissue or cell for generating H2S2 at the location-specific site.

### Claim 13 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is attached to a protein.

### Claim 14 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is attached to an H2S donor.

### Claim 15 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety reacts with H2S and oxygen of the sulfine moiety is removed producing a compound comprising a C═S moiety.

### Claim 16 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety reacts with H2S and oxygen of the sulfine moiety is removed producing a compound comprising a C═S moiety and wherein the compound comprising a C═S moiety reacts with an oxidant to regenerate the compound with a sulfine moiety.

### Claim 17 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is introduced to a biological site within an individual.

### Claim 18 (depends on 1)

The method of claim 1 wherein the compound comprising a sulfine moiety is introduced to cells within an individual.

### Claim 19

A compound of formula
X1 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R1 is absent when X1 is oxygen, sulfur or double bonded nitrogen;
X2 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R2 is absent when X2 is oxygen, sulfur or double bonded nitrogen;
X3 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R3 is absent when X3 is oxygen, sulfur or double bonded nitrogen;
X4 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon, atom wherein R4 is absent when X4 is oxygen, sulfur or double bonded nitrogen;
X5 is an oxygen atom, a nitrogen atom, a sulfur atom or a carbon atom, wherein R5 is absent when X5 is oxygen, sulfur or double bonded nitrogen;
with the proviso that no more than two of X1, X2, X3, X4, X5 may be an atom other than carbon, i.e. a heteroatom,
R1 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R2 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R3 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker;
R4 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker; and
R5 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker.
R1, R2, R3, R4, and R5 may be the same or different,
wherein R1, R2, R3, R4, or R5 or the linker may optionally be bound to a protein, antibody, receptor, ligand, antibody, delivery molecule, device, particle or H2S donating compound.

### Claim 20 (depends on 19)

The compound of claim 19 being

### Claim 21 (depends on 19)

The compound of claim 19 being

### Claim 22 (depends on 19)

The compound of claim 19 being

### Claim 23 (depends on 19)

The compound of claim 19 being

### Claim 24 (depends on 19)

The compound of claim 19 being

### Claim 25 (depends on 20)

The compound of claim 20 being

### Claim 26 (depends on 19)

The compound of claim 19 wherein
R5 and R4 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted, or
R4 and R3 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted, or
R3 and R2 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted.

### Claim 27 (depends on 26)

The compound of claim 26 being

### Claim 28

A compound of formula
wherein
R1 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker,
R2 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker, wherein
R1 and R2 can optionally be part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted.

### Claim 29 (depends on 28)

The compound of claim 28 being

### Claim 30 (depends on 19)

The compound of claim 19 attached to a protein.

### Claim 31 (depends on 19)

The compound of claim 19 attached to an H2S donating compound.

### Claim 32 (depends on 19)

A pharmaceutical composition comprising a compound of claim 19 and a pharmaceutically acceptable vehicle or excipient.

### Claim 33 (depends on 32)

The pharmaceutical composition of claim 32 wherein the compound is attached to a protein or an H2S donating compound.

### Claim 34 (depends on 19)

A method of persulfidation of a target protein comprising
reacting a compound of claim 19 with H2S to produce H2S2 in the presence of a protein, and
wherein the H2S2 persulfidates the target protein.

### Claim 35 (depends on 19)

A method of treating a patient comprising administering a compound of claim 19 to the patient in a therapeutically effective amount to generate a therapeutically effective amount of H2S2.

### Claim 36 (depends on 1)

The method of claim 1 wherein the compound is

### Claim 37 (depends on 6)

The method of claim 6 wherein
R5 and R4 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted, or
R4 and R3 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted, or
R3 and R2 is part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted.

### Claim 38 (depends on 37)

The method of claim 37 wherein the compound of claim is

### Claim 39 (depends on 1)

The method of claim 1 wherein the compound is of formula
wherein
R1 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker,
R2 is hydrogen, carboxyl, ester, acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocyclic, or a heteroatom or a linker, wherein
R1 and R2 can optionally be part of a fused ring structure such as a C5-C7 cyclic structure, saturated or unsaturated, heterocyclic or nonheterocyclic, substituted or unsubstituted.

### Claim 40 (depends on 39)

The method of claim 39 wherein the compound is
